Atlas Trials

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

Clinical trial NCT04716946 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04716946
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
NSCLCNon-small Cell Lung CancerLung CancerNon-small Cell Lung Cancer Stage INon-small Cell Lung Cancer Stage IINon-small Cell Lung Cancer Stage IIINon-small Cell Lung Cancer Stage IIIAPD-L1 Gene Mutation
Start date
2021-01-27
Primary completion
2027-02-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.